This study was undertaken to compare and contrast the views of pharmacists, general practitioners (GPs) and the general public on the value or otherwise of pharmacy-generated patient information leaflets.
All three groups perceived these leaflets to be useful and an aid to improving compliance.
Concerning the information included in leaflets, GPs rated the inclusion of a section on side-effects as being the least important, whilst pharmacists and the general public rated information on the storage of medicines as being least important.
Pharmacists'estimates on what percentage of patients actually read leaflets were significantly lower than estimates by the general public.
General practitioners and pharmacists generally concurred on the types of patients for whom leaflets are considered unsuitable, although a significantly higher percentage of pharmacists than GPs identified unsuitable patients.
There were reservations by the pharmacists concerning the cost-effectiveness of leaflet facilities and on the value of leaflets compared with verbal counselling.
The general public expressed the view that a leaflet facility would affect their choice of pharmacy and that they would be prepared to wait an additional short time to receive such a leaflet.
Almost all GPs thought that it was in the patient's best interest to receive an information leaflet.
Mots-clés Pascal : Médicament, Information thérapeutique, Emballage, Evaluation, Médecin généraliste, Pharmacien, Malade, Consommateur, Royaume Uni, Europe
Mots-clés Pascal anglais : Drug, Therapeutic information, Packaging, Evaluation, General practitioner, Chemist, Patient, Consumer, United Kingdom, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0533571
Code Inist : 002B02A07. Création : 13/02/1998.